securities class action

Mereo BioPharma faces securities lawsuit for allegedly making false statements about setrusumab trial results, causing artificially inflated stock prices and investor losses.

F5 investors have until Feb. 17, 2026, to join securities class action over allegedly misleading statements regarding revenue outlook and undisclosed security incidents.

Varonis Systems faces securities lawsuit alleging false revenue projection statements. Investors who purchased stock February-October 2025 may be eligible for claims by March 9, 2026 deadline.

PomDoctor Ltd. faces securities lawsuit alleging false statements, social media manipulation, and insider selling. Investors who bought stock October-December 2025 must act before April 7, 2026 deadline.

Kyndryl stock crashed 55% after revealing internal control weaknesses, executive departures, and SEC enforcement inquiries. Securities lawsuit filed alleging investor misrepresentation.

Law firm Hagens Berman investigates Ardent Health for securities fraud over $97M accounting adjustments. Stock fell 33% after November disclosure of revenue revisions and reserve increases.

Rosen Law Firm seeks lead plaintiffs for securities lawsuit against Smart Digital Group, alleging false statements and insider trading. Deadline: March 16, 2026.

Beyond Meat faces securities lawsuit over allegedly false asset valuations. Investors must take legal action by March 24, 2026 deadline.

Rosen Law Firm sues Sallie Mae for false disclosures on loan delinquencies. Investors have until February 17, 2026 deadline to join the class action lawsuit.

Bath & Body Works faces securities lawsuit alleging false strategy claims. Investors who bought stock June 2024-November 2025 may qualify; March 16 deadline for lead plaintiff motions.

Ardent Health faces securities lawsuit alleging accounting fraud to overstate revenue through manipulated accounts receivable and delayed uncollectible recognition during 2024-2025.

Rosen Law Firm sues Ultragenyx for securities fraud, alleging executives misrepresented drug efficacy. Investors who bought stock August 2023-December 2025 can claim damages by April 6, 2026 deadline.

Rosen Law Firm initiates securities class action against Richtech Robotics for allegedly making false statements about a non-existent Microsoft partnership, causing shareholder losses.

Rosen Law Firm filed a securities class action against Agilon Health for allegedly making false 2025 guidance statements. Investors harmed between February-August 2025 can participate; deadline March 2, 2026.

uniQure faces securities lawsuit alleging misleading statements about AMT-130's FDA pathway. Stock dropped 49% after FDA reversed stance. Investors have April deadline for lead plaintiff claims.

Fermi Inc. faces securities lawsuit after major tenant canceled $150M funding deal, causing 52% stock decline. Investors must file claims by March 6.

Beyond Meat faces securities lawsuit over delayed disclosure of $77.4M asset impairment charges, causing stock decline. Investors with losses exceeding $75K may join litigation.

Klarna faces securities lawsuit alleging IPO misstatements about loan loss reserves. Investors have until February 20 to join class action.

Law firm investigates Ardent Health for allegedly false financial disclosures. Stock fell 33.81% after company revealed $43M revenue cut, $54M liability increase. Investors have until March 9 to join class action.

Vistagen faces securities class action over alleged misleading statements about drug fasedienol. Investors who purchased stock April 2024-December 2025 can join by March 16, 2026 deadline.